Latest in News & Research
FDA Approves Once-Monthly Andembry for Hereditary Angioedema
The monoclonal antibody is a self-administered injection for prophylactic use to prevent attacks
'Clefting' Linked to Malignancy in Melanocytic Lesions
Clefting identified in 40 percent of melanomas and 6 percent of benign lesions
Povorcitinib Leads to Substantial Repigmentation in Nonsegmental Vitiligo
Significant improvement seen in total-Vitiligo Area Scoring Index from baseline at week 24 for povorcitinib versus placebo
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
One-time surgical application of prademagene zamikeracel improves wound healing and pain
FDA Approves Dupixent for Bullous Pemphigoid
Benefits include sustained disease remission, reductions in itch, lower oral corticosteroids dose
Launch Alert: FDA Approves Dupixent (Dupilumab) for Adults with Bullous Pemphigoid
Dupixent is the first and only FDA-approved treatment for bullous pemphigoid, demonstrating significant itch and blister reduction in clinical trials
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
Patients belonging to haplogroup T exhibit unique nivolumab-resistant baseline peripheral CD8+ T-cell repertoire
AI Model Can Aid Physicians in Skin Cancer Diagnoses
PanDerm was evaluated on a wide range of clinical tasks and trained on multiple image types
Psoriasis Risk Higher for Patients With Eczema Treated With Dupilumab
Three-year cumulative psoriasis incidence higher for those receiving dupilumab versus other systemic agents
Novel System Outperforms Existing Prognostication Models for Squamous Cell Carcinoma
Artificial intelligence-derived risk score prognostication system demonstrated superior sensitivity across all outcomes
Second Course of Adjuvant Treatment Feasible in Stage III to IV Melanoma
Recurrence-free survival for second course of adjuvant treatment is lower with PD-1 checkpoint inhibitors versus BRAF + MEK inhibitors
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
Findings support observational epidemiology showing protective effect of dog exposure early in life
Pediatric Skin Care Regimens on TikTok Offer Few Benefits, Possible Harm
Average of 11, maximum of 21 potentially irritating active ingredients included in top 25 most-viewed videos
3D Total Body Photography Helpful for Diagnosing Skin Disease
Patients mostly expressed positive views on this technology, while privacy and shame were identified as barriers to its use
Formulation Focus: ISDIN: Advanced Sunscreen Formulations with Photolyases and Antioxidants
James Q. Del Rosso, DO reviews two of ISDIN’s photoprotection products: Eryfotona Actinica and Eryfotona Actinica Ageless
Substantial and Increasing Burden of Skin Cancer Seen in Older Adults
Only incidence and prevalence rates attributable to keratinocyte cancer, DALYs attributable to BCC would increase by 2050
Psoriasis Tied to Increased Risk for Sleep Disorders
Psoriasis was significantly associated with restless leg syndrome, insomnia, and obstructive sleep apnea
Tiny Baby’s Life-Threatening Wound Healed With Fish Skin
Key Takeaways
A rare fish skin treatment helped heal a premature baby's severe wound
The product helped tissue grow without needing surgery
The baby...
Central Adiposity Measures Associated With Psoriasis Risk
Significant interaction seen for full psoriasis polygenic risk score with waist-to-hip ratio on psoriasis risk
Adalimumab Comparable to Adalimumab + Methotrexate for Plaque Psoriasis
No difference seen in effectiveness of adalimumab monotherapy versus adalimumab with concomitant methotrexate
Avelumab + Cetuximab Ups Survival in Advanced Cutaneous Squamous Cell Carcinoma
Progression-free survival significantly improved with avelumab + cetuximab versus avelumab alone
Roflumilast Foam Improves Signs and Symptoms of Psoriasis
More patients in roflumilast group achieved scalp-IGA and body-IGA success at week 8 versus vehicle group
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
Topical anti-inflammatories should be applied once to twice daily to active eczema patches
24 of 1274